Arix's Global Reach
Our global network and transatlantic team provide us with access to a large pool of opportunities, wide scientific networks and a deep understanding of the industries and markets that we invest in.
Academic and pharmaceutical partnerships provide access to extensive R&D insights and due diligence capabilities. Through these networks we can provide portfolio companies with the additional capital, expertise and networks they need to become global leaders.
How We Source
Arix has developed a wide network that includes research accelerators, universities, venture capital networks and pharmaceutical companies. Through this network, Arix is able to identify new technologies and discoveries that provide a rich pipeline of potential investments.
Read more on our partnerships
Arix Net Asset Value (NAV)
Over the last year, net asset value increased by 85%; NAV per share increased by 32%
NAV per share
Click on the individual sections to view more.
Read more on Portfolio Review